- Home
- NSSC vs ATAI Comparison
NSSC vs ATAI Comparison
Compare NSSC & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NSSC | ATAI |
|---|---|---|
| Founded | 1969 | 2018 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | NSSC | ATAI |
|---|---|---|
| Price | $42.76 | $4.07 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 6 |
| Target Price | ★ $47.50 | $14.33 |
| AVG Volume (30 Days) | 399.8K | ★ 3.2M |
| Earning Date | 02-02-2026 | 11-12-2025 |
| Dividend Yield | ★ 1.31% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.23 | N/A |
| Revenue | ★ $186,786,000.00 | $3,018,000.00 |
| Revenue This Year | $13.13 | $943.18 |
| Revenue Next Year | $9.55 | N/A |
| P/E Ratio | $34.78 | ★ N/A |
| Revenue Growth | N/A | ★ 811.78 |
| 52 Week Low | $19.00 | $1.15 |
| 52 Week High | $48.12 | $6.75 |
Technical Indicators
Market Signals| Indicator | NSSC | ATAI |
|---|---|---|
| Relative Strength Index (RSI) | 54.95 | 45.25 |
| Support Level | $41.64 | $3.88 |
| Resistance Level | $44.01 | $4.72 |
| Average True Range (ATR) | 1.26 | 0.25 |
| MACD | 0.08 | 0.03 |
| Stochastic Oscillator | 60.43 | 23.81 |
Price Performance
Historical ComparisonAbout NSSC NAPCO Security Technologies Inc.
NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses. Geographically, the company derives a majority of its revenue from the United States.
About ATAI ATAI Life Sciences N.V.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.